High expression of monoamine oxidases in human white adipose tissue: Evidence for their involvement in noradrenaline clearance

Biochemical Pharmacology

Volumn 58, Issue 11, 1999, Pages 1735-1742

  Pizzinat, Nathalie ^a   Marti, Luc ^b   Remaury, Anne ^a   Leger, Frederic ^b   Langin, Dominique ^b   Lafontan, Max ^b   Carpéné, Christian ^b   Parini, Angelo ^a  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

Author keywords

Adipocyte; Human; Monoamine oxidases; Noradrenaline transporter

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BUPRANOLOL; CARRIER PROTEIN; CLORGYLINE; CORTICOSTERONE; DESIPRAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PHENTOLAMINE; SELEGILINE; TYRAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; NORMAL HUMAN; NORTHERN BLOTTING; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADRENERGIC ALPHA-AGONISTS; ADULT; BIOLOGICAL TRANSPORT; FEMALE; HUMANS; ISOENZYMES; MONOAMINE OXIDASE; NOREPINEPHRINE;

EID: 0032699979     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00270-1     Document Type: Article

References (37)

1. Weyler H., Hsu Y.P.P., Breakefield X.O. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther. 47:1990;391-417.
2. Cesura A.M., Gottowik J., Lahm H.W., Lang G., Imhof R., Malherbe P., Röthlisberger U., Da Prada M. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis. Eur J Biochem. 236:1996;996-1002.
3. 2-imidazoline binding sites on monoamine oxidases. J Biol Chem. 270:1995;9856-9861.
4. Parini A., Gargalidis-Moudanos C., Pizzinat N., Lanier S.M. The elusive family of imidazoline binding sites. Trends Pharmacol Sci. 17:1996;13-16.
5. + . J Pharmacol Exp Ther. 276:1996;359-364.
6. Raddatz R., Parini A., Lanier S.M. Localization of the imidazoline binding domain on monoamine oxidase B. Mol Pharmacol. 52:1997;549-553.
7. Saura J., Bleuel Z., Ulrich J., Mendelowitsch A., Chen K., Shih J.C., Malherbe P., Da Prada M., Richards J.G. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience. 70:1996;755-774.
8. Luque J.M., Kwan S.W., Abell C.W., Da Pada M., Richards J.G. Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system. J Comp Neurol. 363:1995;665-680.
9. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., Van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 262:1993;578-580.
10. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C., De Maeyer E. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO A. Science. 268:1995;1763-1766.
11. Oreland L. Monoamine oxidase in neuro-psychiatric disorders. Yashuhara H., Parvez S.H., Oguchi K., Sandler M., Nagatsu T. Monoamine Oxidase Basic and Clinical Aspects . 1993;219-247 VSP, Utrecht.
12. Saura J., Kettler R., Da Prada M., Richards J.G. Quantitative enzyme radioautography with 3H-Ro 411049 and 3H-Ro 196327 in vitro Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain . J Neurosci. 12:1992;1977-1999.
13. Mannelli M., Pupilli C., Lanzillotti R., Ianni L., Serio M. Catecholamines and blood pressure regulation. Horm Res. 34:1990;156-160.
14. Kopin I.J. Monoamine oxidase (MAO) Relationship to foods, poisons and medicines . Biogenic Amines. 9:1993;355-365.
15. Stock K., Westermann E.O. Concentration of norepinephrine serotonin, and histamine, and of amine-metabolizing enzymes in mammalian adipose tissue. J Lipid Res. 4:1963;297-304.
16. Elia M., Kurpad A.V., MacDonald I., Coppack S.W., Frayn K.N. Effect of noradrenaline infusion on the net exchange of noradrenaline across human adipose tissue and muscle in vivo. Endocrinol Metabol. 3:1996;31-35.
17. Samra J.S., Simpson E.J., Clark M.L., Forster C.D., Humphreys S.M., MacDonald I.A., Frayn K.N. Effects of epinephrine infusion on adipose tissue Interactions between blood flow and lipid metabolism . Am J Physiol. 271:1996;E834-E839.
18. 2-adrenergic binding sites . Mol Pharmacol. 37:1990;876-885.
19. Carpéné C., Marti L., Hudson A., Lafontan M. Nonadrenergic imidazoline binding sites and amine oxydase activities in fat cells. Ann N Y Acad Sci. 763:1995;380-397.
20. Yu PH, Monoamine oxidase. In: Neuromethods, Neurotransmitter Enzymes (Eds. Boulton AA, Baker GB and Yu PH) 5: 235-272, 1986.
21. Fowler C.J., Oreland L. The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxidase and oxygen. Biochem Pharmacol. 29:1980;2225-2233.
22. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
23. Olefsky J.M. Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J. 172:1978;137-145.
24. Raimondi L., Pirisino R., Ignesti G., Capecchi S., Banchelli G., Buffoni F. Semicarbazide-sensitive amine oxidase activity (SSAO) of rat epididymal white adipose tissue. Biochem Pharmacol. 41:1991;467-469.
25. Barrand M.A., Callingham B.A. Monoamine oxidase activities in brown adipose tissue of the rat Some properties and subcellular distribution . Biochem Pharmacol. 31:1982;2177-2184.
26. Singer T.P., Ramsay R.R. New aspects of the substrate specificities, kinetic mechanisms and inhibition of monoamine oxidases. Yasuhara H., Parvez S.H., Oguchik, Sandler M., Nagatsu T. Monoamine oxidase Basic and Clinical Aspects . 1993;23-43 VSP, Utrecht.
27. Lanier B., Raddatz R., Bakthavachalam V., Coupry I., Neumeyer J.L., Lanier S.M. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mol Pharmacol. 48:1995;703-710.
28. 2 imidazoline ligands in intact cells . Mol Pharmacol. 51:1997;637-643.
29. Ricquier D., Cassard-Doulcier A.M. The biochemistry of white and brown adipocytes analysed from a selection of proteins. Eur J Biochem. 278:1993;785-796.
30. Vikman H.L., Kaartinen J.M., Tuominen R.K., Ohisalo J.J. A possible role for protein kinase C in the regulatory differences between intra-abdominal and subcutaneous human adipose tissue. Clin Sci (Colch). 85:1993;265-268.
31. Russ H., Sonna J., Keppler K., Baunach S., Schömig E. Cyanine-related compounds A novel class of potent inhibitors of extraneuronal noradrenaline transport . Naunyn Schmiedebergs Arch Pharmacol. 348:1993;458-465.
32. Lewinsohn R., Glover V., Sandler M. Development of benzylamine oxidase and monoamine oxidase A and B in man. Biochem Pharmacol. 29:1980;1221-1230.
33. Grimsby J., Lan N.C., Neve R., Chen K., Shih J.C. Tissue distribution of human monoamine oxidase A and B mRNA. J Neurochem. 55:1990;1166-1169.
34. Graefe K.H., Friedgen B., Wolfel R., Bossle F., Russ H., Schömig E. 1,1′-Diisopropyl-2,4′-cyanine (disprocynium24), a potent uptake 2 blocker, inhibits the renal excretion of catecholamines. Naunyn Schmiedebergs Arch Pharmacol. 356:1997;115-125.
35. Paczowski N.J., Vuocolo H.E., Bryan-Lluka L.J. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat. Naunyn Schmiedebergs Arch Pharmacol. 353:1996;423-430.
36. Tong J.H., D'Iorio A., Kandaswami C. On the characteristics of mitochondrial monoamine oxidase in pancreas and adipose tissues from genetically obese mice. Can J Biochem. 57:1979;197-200.
37. Bray G.A. The Mona Lisa hypothesis. Most obesities known are low in sympatheric activity. Oomura Y., Tarui S., Inoue S., Shimazu T. Progress in Obesity Research. 1991;61-66 John Libbey & Company Ltd, London.